Famitinib

Overview

Famitinib has been used in trials studying the treatment of Colorectal Cancer, Renal Cell Cancer, Colorectal Cancer Recurrent, Colorectal Cancer Metastatic, and Metastatic Renal Cell Cancer, among others.

Background

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title	Posted	Study ID	Phase	Status	Sponsor
Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± Camrelizumab	2024/07/23	NCT06516289	Phase 2	Recruiting	Fudan University
A Study of Adebrelimab Combined With Famitinib and Chemotherapy in the Treatment of ES-SCLC.	2024/03/12	NCT06306560	Phase 2	Not yet recruiting	Harbin Medical University
Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.	2023/03/08	NCT05760378	Phase 3	Recruiting	Fudan University
SNF Platform Study of HR+/ HER2-advanced Breast Cancer	2022/10/26	NCT05594095	Phase 2	Recruiting	Fudan University
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy	2022/10/17	NCT05582499	Phase 2	Recruiting	Fudan University
Single Dose Study To Study The Absorption, Metabolism And Excretion Of Famitinib	2022/07/26	NCT05473468	Phase 1	Active, not recruiting	Jiangsu HengRui Medicine Co., Ltd.
Bioequivalence Study of Famitinib Malate in Healthy Volunteers Under Fasting Condition	2022/04/20	NCT05336279	Phase 1	Completed	Jiangsu HengRui Medicine Co., Ltd.
A Study of SHR-1802 in Patients With Advanced Solid Tumor	2022/01/26	NCT05208177	Phase 2	Recruiting	Jiangsu HengRui Medicine Co., Ltd.
Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer	2022/01/04	NCT05176080	Phase 1	Terminated	Henan Cancer Hospital
A Study to Evaluate Camrelizumab Combined With Famitinib as Subsequent Therapy in Patients With Advanced NSCLC	2021/11/03	NCT05106335	Phase 3	Terminated	Jiangsu HengRui Medicine Co., Ltd.

FDA Drug Approvals

Approved Product	Manufacturer	NDC Code	Route	Strength	Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product	Authorization Holder	Status	Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product	Manufacturer	Approval Number	Dosage Form	Strength	Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product	Company	Approval Number	Drug Type	Dosage Form	Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product	Registration No.	Company	Licence No.	Strength	Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product	ARTG ID	Sponsor	Registration Type	Status	Registration Date
No TGA approvals found for this drug.

AI-Powered Research

Premium Access